GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shire PLC (NAS:SHPG) » Definitions » Price-to-Operating-Cash-Flow

Shire (SHPG) Price-to-Operating-Cash-Flow : 12.63 (As of Apr. 26, 2024)


View and export this data going back to 1998. Start your Free Trial

What is Shire Price-to-Operating-Cash-Flow?

As of today (2024-04-26), Shire's share price is $179.20. Shire's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2018 was $14.19. Hence, Shire's Price-to-Operating-Cash-Flow Ratio for today is 12.63.

The historical rank and industry rank for Shire's Price-to-Operating-Cash-Flow or its related term are showing as below:

SHPG's Price-to-Operating-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 24.725
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Shire's Cash Flow from Operations per share for the three months ended in Sep. 2018 was $2.79. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2018 was $14.19.


Shire Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Shire's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shire Price-to-Operating-Cash-Flow Chart

Shire Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.34 10.13 18.08 18.67 10.94

Shire Quarterly Data
Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.42 10.94 9.04 11.61 13.14

Competitive Comparison of Shire's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Shire's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shire's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shire's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Shire's Price-to-Operating-Cash-Flow falls into.



Shire Price-to-Operating-Cash-Flow Calculation

Shire's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=179.20/14.188
=12.63

Shire's Share Price of today is $179.20.
Shire's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $14.19.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Shire Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Shire's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Shire (SHPG) Business Description

Industry
Traded in Other Exchanges
N/A
Address
Shire is a diversified, Ireland-based specialty drug firm. Shire has grown primarily through mergers and acquisitions, including the Transkaryotic Therapies acquisition in 2005, which established its genetic disease business with Replagal and Elaprase, and the merger with New River in 2007, which brought full rights to neuroscience drug Vyvanse. Shire completed the acquisition of ViroPharma (genetic diseases) in 2014, NPS Pharma (internal medicine) in 2015, and Baxalta (hematology, immunology, and oncology) and Dyax (genetic diseases) in 2016.
Executives
James H Cavanaugh director 265 HOTHORPE LANE, VILLANOVA PA 19085

Shire (SHPG) Headlines